Chemotherapy-induced nausea and vomiting
Conditions
Interventions
Chemotherapy-related nausea and vomiting group/observation group without chemotherapy-related nausea and vomiting:None
Sponsors
Tianjin Cancer Institute &Hospital
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Liver malignant tumor was diagnosed by histological or cytological examination; 2. Age >= 16 years old; 3. Expected survival time >=3 months; 4. There were no obvious abnormalities in liver and kidney function, blood routine and electrocardiogram before treatment. 5. HAIC or TACE interventional therapy was performed; 6. Antiemetic agents were given according to the guidelines and expert consensus on the prevention and treatment of vomiting related to tumor treatment; 7. Be able to communicate with medical staff; 8. Informed consent to participate in this study.
Exclusion criteria
Exclusion criteria: 1.Currently suffering from intestinal obstruction, with severe digestive tract diseases or a history of such conditions; 2. Concurrent chemoradiotherapy; 3. Combined with brain metastases or other diseases that can lead to increased intracranial pressure; 4. Have a history of mental illness or have recently experienced other major stressful events; 5. Strong opioid drugs have been used within the last week.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy-induced nausea and vomiting;Quality of life evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Area under the receiver operating characteristic curve, AUC;Accuracy;Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactYongjian Wang
Tianjin Cancer Institute &Hospital
Outcome results
None listed